Technical Analysis for ABEO - Abeona Therapeutics Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.40 | -3.51% | -0.16 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| 200 DMA Resistance | Bearish | -3.51% | |
| Wide Bands | Range Expansion | -3.51% | |
| Volume Surge | Other | -7.95% | |
| Inside Day | Range Contraction | -7.95% | |
| Wide Bands | Range Expansion | -7.95% | |
| Up 3 Days in a Row | Strength | -7.95% |
| Alert | Time |
|---|---|
| Down 5% | about 15 hours ago |
| Possible NR7 | about 15 hours ago |
| 60 Minute Opening Range Breakdown | about 16 hours ago |
| Up 1% | about 18 hours ago |
| Down 3% | about 19 hours ago |
Get a Trading Assistant
- Earnings date: 05/09/2024
Abeona Therapeutics Inc. Description
Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Biology Emerging Technologies Rare Diseases Molecular Biology Genetics Gene Therapy Genetic Engineering Anemia CRISPR Genome Editing Adeno Associated Virus Cas9 Severe And Rare Diseases Blood Diseases Fanconi Anemia
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.01 |
| 52 Week Low | 2.85 |
| Average Volume | 736,643 |
| 200-Day Moving Average | 5.06 |
| 50-Day Moving Average | 6.78 |
| 20-Day Moving Average | 5.40 |
| 10-Day Moving Average | 4.04 |
| Average True Range | 0.63 |
| RSI (14) | 38.65 |
| ADX | 23.93 |
| +DI | 24.90 |
| -DI | 29.45 |
| Chandelier Exit (Long, 3 ATRs) | 6.55 |
| Chandelier Exit (Short, 3 ATRs) | 4.95 |
| Upper Bollinger Bands | 9.17 |
| Lower Bollinger Band | 1.64 |
| Percent B (%b) | 0.37 |
| BandWidth | 139.44 |
| MACD Line | -0.79 |
| MACD Signal Line | -0.81 |
| MACD Histogram | 0.0231 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.84 | ||||
| Resistance 3 (R3) | 4.87 | 4.74 | 4.77 | ||
| Resistance 2 (R2) | 4.74 | 4.63 | 4.73 | 4.74 | |
| Resistance 1 (R1) | 4.57 | 4.56 | 4.51 | 4.55 | 4.72 |
| Pivot Point | 4.45 | 4.45 | 4.42 | 4.44 | 4.45 |
| Support 1 (S1) | 4.28 | 4.34 | 4.22 | 4.25 | 4.08 |
| Support 2 (S2) | 4.15 | 4.27 | 4.14 | 4.06 | |
| Support 3 (S3) | 3.98 | 4.15 | 4.03 | ||
| Support 4 (S4) | 3.96 |
